BackHeartBeam Overview
HeartBeam Inc

HeartBeam Target Price

Analysts' average 12-month price target for HeartBeam is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.5

Average Target Price

$2.00302.7% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-14Maxim Group$2302.7% upsideOpen
2025-12-11H.C. WainwrightYi Chen$5.51007.5% upsideOpen
2025-12-10UBSYi Chen$5.51007.5% upsideOpen
2025-12-08H.C. Wainwright$2.5403.4% upsideOpen
2025-10-31Roth Capital$4705.5% upsideOpen
2022-12-02Industrial Alliance Securities$101913.7% upsideOpen

HeartBeam (BEAT) FAQ

As of the most recent data, BEAT shows a target price of $2. Scroll down for historical charts and peer comparison views.

If HeartBeam moved to the average analyst target of $2, shares would be roughly 302.7% higher than $0.5. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of HeartBeam's earnings trajectory.

Besides this target price page, Stockcircle has HeartBeam's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $2) with ownership activity and broader fundamentals.

HeartBeam's target price is $2; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.